Tower Research Capital (TRC)’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.4K | Buy |
|
|||||
|
2025
Q1 | $33K | Sell |
|
|||||
|
2024
Q4 | $200K | Buy |
|
|||||
|
2024
Q3 | $15.3K | Sell |
|
|||||
|
2024
Q2 | $79.6K | Sell |
|
|||||
|
2024
Q1 | $145K | Buy |
|
|||||
|
2023
Q4 | $55.5K | Buy |
|
|||||
|
2023
Q3 | $5.17K | Sell |
|
|||||
|
2023
Q2 | $10.3K | Sell |
|
|||||
|
2023
Q1 | $11K | Buy |
|
|||||
|
2022
Q4 | $8K | Sell |
|
|||||
|
2022
Q3 | $14K | Buy |
|
|||||
|
2022
Q2 | $8K | Sell |
|
|||||
|
2022
Q1 | $51K | Buy |
|
|||||
|
2021
Q4 | $24K | Buy |
|
|||||
|
2021
Q3 | $26K | Buy |
|
|||||
|
2021
Q2 | $21K | Buy |
|
|||||
|
2021
Q1 | $21K | Sell |
|
|||||
|
2020
Q4 | $67K | Sell |
|
|||||
|
2020
Q3 | $254K | Buy |
|
|||||
|
2020
Q2 | $98K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $56K | Buy |
|
|||||
|
2019
Q3 | $11K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $17K | Buy |
|
|||||
|
2018
Q3 | $1K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $1K | Sell |
|
|||||
|
2016
Q3 | $5K | Sell |
|
|||||
|
2016
Q2 | $4K | Buy |
|